M.Sc

NIAB, an autonomous institute under the aegis of the Department of Biotechnology, Ministry of Science & Technology, Government of India, is aimed to harness novel and emerging biotechnologies and create knowledge in the cutting edge areas for improving animal health and productivity. The Institute’s research focus is on animal genetics and genomics, transgenesis, stem cell & its applications, reproductive biotechnology, infectious diseases, nanotechnology, bioinformatics and Nutrigenomics.

Glenmark was founded with a vision to emerge as a leading integrated research-based, global pharmaceutical company. Our branded generics business has a significant presence in markets across emerging economies including India.  The generics business services the requirements of developed markets like US and Western Europe. Our API business sells products in over 65 countries including the US, various countries in the EU, South America and India.

Sun Pharma is the fourth largest generic pharmaceutical company in the world It is also Indias largest and most valuable pharmaceutical enterprise by size and market capitalization. The company provides high quality medicines trusted by customers and patients in over ISO countries and has multiple manufacturing facilities and R&D centers. Our leadership is approachable, recognizes people's passions for growth, gives them a voice and empowers them to make a positive change.

Piramal Group has interests in a portfolio of businesses including financial services (Piramal Enterprises Limited), pharmaceuticals (Piramal Pharma Limited), and real estate (Piramal Realty). With operations in 30 countries and brand presence in over 100 markets, the Group’s turnover is ~1.9 billion usd in FY 2022. Driven by its core values, the Group pursues inclusive growth, while adhering to ethical and value-driven practices.

IICB Institute was established in 1935 as the first non official centre in India for biomedical research and was included within the aegis of CSIR in 1956. IICB today is engaged in research on diseases of national importance and biological problems of global interest, employing sophisticated state-of-the-art technology in keeping with the rapid and unprecedented momentum that life science research has gained globally over the last 50 years.

Maithri Drugs is one of Indias fast-growing pharmaceutical companies. Maithris strategic focus is on active pharma ingredients (APIs). The company is widely recognized for its excellent research and development and aggressive growth strategies. Our 39 US DMFs and 14 CEPs in a short span attest to our R&D excellence.

Post : Junior Executive's / Executive's - QC (Method Validation) Department

Aculife Healthcare Pvt. Ltd Company is a part of Nirma Group & it is one of world's largest Infusion & Injectable Company, having a State-of-the art manufacturing facility spread over 550 acres of land located near Ahmedabad, Gujarat. Aculife healthcare has global operation in more than 100 countries and it has subsidiaries in Brazil, Mexico & Vietnam. The manufacturing facility has 2 plants with FFS technology, 1 Glass injectable plant and a one dedicated R&D center equipped with advance technology and unmatched research team.

Ratnatris Pharmaceuticals Pvt. Ltd., a WHO GMP certified "State of Art" manufacturing facility, that manufactures General Therapeutics and Antibiotic Drugs, Tablets, Capsules, Oral Liquid, Dry Powder, and SVP. Ratnatris Pharmaceuticals is having footprints in various countries in Africa, South East Asia, Latin America, Middle East, and CIS Zone.